Allergy/Asthma News

WASHINGTON — Heightened odds for an asthma attack appeared among current tobacco smokers, women and those with a low education level, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Patients with asthma face heightened odds for chronic cough, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN FRANCISCO — Results showed patients with a nickel allergy had equivalent revision rates whether they received a nickel-free implant or not during total knee arthroplasty, as well as similar outcomes as patients without a nickel allergy.

Patients with eosinophilic granulomatosis with polyangiitis and severe eosinophilic asthma showed significant improvements in asthma control and acute vasculitis symptoms after 1 year of benralizumab, according to real-world study results.

The volume of Google searches related to food allergy grew between 2012 and 2022, with specific search topics varying by country, according to a letter published in Clinical and Translational Allergy.

Transportation pollution puts children’s health at risk on a daily basis, but a switch to zero-emission vehicles and clean power would prevent several poor respiratory outcomes in this population, according to a press release.

Data showed that not all patients with chronic inflammatory skin diseases undergo pretreatment testing before initiating systemic immunomodulatory therapies, despite current guidelines, according to a study.

MIAMI BEACH, Fla. — Zabalafin, a nonsteroidal topical, demonstrated efficacy in reducing inflammation and bacteria on the skin of children and adults with atopic dermatitis, according to interim data presented in a poster at Masters of Pediatric Dermatology.

Whole-exome sequencing helped physicians identify undiagnosed primary immunodeficiency diseases in children with community-acquired sepsis, according to a study published in Pediatric Allergy and Immunology.

The FDA has approved omalizumab for use in building tolerance to accidental ingestion of allergens among patients with IgE-mediated food allergy.